82 related articles for article (PubMed ID: 25070755)
1. Prediction of the hemoglobin level in hemodialysis patients using machine learning techniques.
Martínez-Martínez JM; Escandell-Montero P; Barbieri C; Soria-Olivas E; Mari F; Martínez-Sober M; Amato C; Serrano López AJ; Bassi M; Magdalena-Benedito R; Stopper A; Martín-Guerrero JD; Gatti E
Comput Methods Programs Biomed; 2014 Nov; 117(2):208-17. PubMed ID: 25070755
[TBL] [Abstract][Full Text] [Related]
2. Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?
Gabutti L; Lötscher N; Bianda J; Marone C; Mombelli G; Burnier M
BMC Nephrol; 2006 Sep; 7():13. PubMed ID: 16981983
[TBL] [Abstract][Full Text] [Related]
3. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
4. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
6. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
7. Dosage individualization of erythropoietin using a profile-dependent support vector regression.
Martín-Guerrero JD; Camps-Valls G; Soria-Olivas E; Serrano-López AJ; Pérez-Ruixo JJ; Jiménez-Torres NV
IEEE Trans Biomed Eng; 2003 Oct; 50(10):1136-42. PubMed ID: 14560766
[TBL] [Abstract][Full Text] [Related]
8. Predictors of anemia in patients on hemodialysis.
Aasebø W; Hartmann A; Jenssen T
Hemodial Int; 2009 Jul; 13(3):335-9. PubMed ID: 19614760
[TBL] [Abstract][Full Text] [Related]
9. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
Abe M; Okada K; Soma M; Matsumoto K
Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
[TBL] [Abstract][Full Text] [Related]
10. Optimization of anemia treatment in hemodialysis patients via reinforcement learning.
Escandell-Montero P; Chermisi M; Martínez-Martínez JM; Gómez-Sanchis J; Barbieri C; Soria-Olivas E; Mari F; Vila-Francés J; Stopper A; Gatti E; Martín-Guerrero JD
Artif Intell Med; 2014 Sep; 62(1):47-60. PubMed ID: 25091172
[TBL] [Abstract][Full Text] [Related]
11. [Long-acting erythropoetin efficacy in the treatment of nephrogenic anemia in patients with chronic kidney disease during predialysis stage].
Milovanov IuS; Milovanova LIu
Ter Arkh; 2012; 84(6):48-52. PubMed ID: 22997919
[TBL] [Abstract][Full Text] [Related]
12. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
13. [Darbepoetin-alfa treatment of anemia secondary to chronic renal failure in dialysis patients: Results of a French multicenter study].
Kessler M; Hannedouche T; Fitte H; Cayotte JL; Urena P; Réglier JC;
Nephrol Ther; 2006 Sep; 2(4):191-9. PubMed ID: 16966064
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of renal anemia in hemodialysis patients in General Hospital Bjelovar from 2007 to 2010].
Lovcić V; Vujić J; Basić-Jukić N; Kurtović I; Janković RI; Lovcić P; Dzapo M
Acta Med Croatica; 2011 Oct; 65 Suppl 3():49-53. PubMed ID: 23120816
[TBL] [Abstract][Full Text] [Related]
15. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an anemia algorithm in chronic hemodialysis patients.
Nhan J; Jensen L; McMahon A
CANNT J; 2007; 17(3):48-58, 62-73; quiz 59-61, 74-6. PubMed ID: 17944348
[TBL] [Abstract][Full Text] [Related]
18. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
[TBL] [Abstract][Full Text] [Related]
19. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
20. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
